Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Immuron Limited - American Depositary Shares (NQ: IMRN )

1.820 UNCHANGED
Streaming Delayed Price Updated: 3:37 PM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,279
Open 1.810
Bid (Size) 1.760 (5)
Ask (Size) 1.860 (2)
Prev. Close 1.820
Today's Range 1.797 - 1.848
52wk Range 1.700 - 3.090
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS)
From Immuron Limited
Via GlobeNewswire
Immuron Travelan® continued strong sales growth
From Immuron Limited
Via GlobeNewswire

Performance

YTD
+2.49%
+2.49%
1 Month
-9.00%
-9.00%
3 Month
-17.27%
-17.27%
6 Month
-32.25%
-32.25%
1 Year
-35.46%
-35.46%

More News

Read More
Immuron Announces New Research Collaboration targeting Antimicrobial Resistance
From Immuron Limited
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Immuron Announces Travelan® Clinical Trial Update
From Immuron Limited
Via GlobeNewswire
UPDATE: Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online Viewing
From Virtual Investor Conferences
Via GlobeNewswire
Small Cap Growth Virtual Investor Conference Agenda Announced for December 5th
From Virtual Investor Conferences
Via GlobeNewswire
Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing
Via ACCESSWIRE
Small Cap Growth Virtual Investor Conference Agenda Announced for December 5th
From Virtual Investor Conferences
Via GlobeNewswire
Immuron CEO, Steven Lydeamore to Present at the Small Cap Growth Virtual Investor Conference December 5th
From Immuron Limited
Via GlobeNewswire
Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap Event
From Immuron Limited
Via GlobeNewswire
Immuron Limited to Present at November 21st Virtual Investor Summit Microcap Event
Via ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Immuron CEO, Steven Lydeamore participation in Maxim Virtual Healthcare Conference
From Immuron Limited
Via GlobeNewswire
Immuron Travelan® continued strong sales growth
From Immuron Limited
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
NMRC Reports Results for Campylobacter Controlled Human Infection Model Study
From Immuron Limited
Via GlobeNewswire
Immuron Plans Phase 2 Trial for IMM-529 following FDA review
From Immuron Limited
Via GlobeNewswire
Immuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan®
From Immuron Limited
Via GlobeNewswire
Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference
From Immuron Limited
Via GlobeNewswire
Immuron CEO, Steven Lydeamore to host webinar on MarketOpen Direct Connect
From Immuron Limited
Via GlobeNewswire
Immuron announces record Travelan® sales globally, Australia and USA
From Immuron Limited
Via GlobeNewswire
Immuron requests pre-IND meeting for IMM-529 with FDA filing
From Immuron Limited
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.